Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 1068

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 7
Chunk 1068
---
 Table Total for Non-PEO NEOs(5) ($)  
     Average
                                            Compensation Actually Paid to Non-PEO NEOs(6) ($)  
     Value
                                            of Initial Fixed $100 Investment Based On Total Shareholder Return(7) ($)  
     Net
                                            Income (Loss) (millions)(8) ($) 
  
     (a)  
     (b)  
     (c)  
     (b)  
     (c)  
     (d)  
     (e)  
     (f)  
     (h) 
  
     2025  
    $–  
    $–  
    $500,000  
    $495,402  
    $430,844  
    $430,875  
    $2.45  
    $(13.40)
  
     2024  
    $505,332  
    $395,249  
    $416,449  
    $400,496  
    $404,032  
    $385,270  
    $8.28  
    $(12.21)
  
     2023  
    $460,000  
    $(62,027) 
     –  
     –  
    $388,750  
    $220,700  
    $18.84  
    $(12.03)

    (1)
    The dollar amounts reported in these columns (b) are the amounts of total compensation reported for our respective PEOs for each corresponding year in the “Total” column of the Summary Compensation Table. Refer to “Executive Compensation — Summary Compensation Table.”

    (2)
    Charles J. Fisher, Jr., M.D. served as the Company’s Chief Executive Officer for the entirety of the year fiscal year ended March 31, 2023 and through November 7, 2023, and served as the Company’s PEO for such period.

    (3)
    James B. Frakes was appointed as the Company’s Chief Executive Officer, effective November 7, 2023, and served as the Company’s PEO from such date through March 31, 2024.

    (4)
    The dollar amounts reported in columns (c) represent the amount of “compensation actually paid” to Dr. Fisher and Mr. Frakes in the periods